Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00276419 |
Recruitment Status :
Terminated
(Lack of funds; FDA approved a topical form of diclofenac during study, no need to continue study of pharmacy-compounded drug.)
First Posted : January 13, 2006
Results First Posted : December 13, 2012
Last Update Posted : December 20, 2012
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breast Pain Non-cyclical Mastalgia Surgical Scar-Related Breast Pain | Drug: Diclofenac Drug: Placebo | Phase 2 Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 25 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Topical Diclofenac for the Treatment of Noncyclic Breast Pain |
Study Start Date : | June 2005 |
Actual Primary Completion Date : | May 2009 |
Actual Study Completion Date : | May 2009 |

Arm | Intervention/treatment |
---|---|
Experimental: Placebo First, then Diclofenac (Arm A)
Placebo for Diclofenac in topical cream applied to the skin three times daily for 10 weeks, then compounded topical Diclofenac cream applied to the skin three times daily for 10 weeks.
|
Drug: Diclofenac
Compounded topical diclofenac cream applied to the skin three times daily for 10 weeks
Other Names:
Drug: Placebo Placebo for Diclofenac in topical cream applied to the skin three times daily for 10 weeks |
Experimental: Diclofenac First, then Placebo (Arm B)
Compounded topical Diclofenac cream applied to the skin three times daily for 10 weeks, then placebo for Diclofenac in topical cream applied to the skin three times daily for 10 weeks.
|
Drug: Diclofenac
Compounded topical diclofenac cream applied to the skin three times daily for 10 weeks
Other Names:
Drug: Placebo Placebo for Diclofenac in topical cream applied to the skin three times daily for 10 weeks |
- Frequency of Breast Pain [ Time Frame: 4 weeks, 10 weeks ]Participants will complete a breast pain diary indicating the sensation of pain on a daily basis. The frequency of breast pain will be determined by the number of days per week that the subject recorded experiencing pain at 4 weeks and 10 weeks of each treatment.
- Severity of Breast Pain [ Time Frame: 4 weeks, 10 weeks ]Severity will measured using a 100 mm visual analog scale (VAS). The VAS does not have any pre-set marks between the extremes. For the pain severity VAS, 0 means no pain and 100 means extreme pain. The investigator measures the written mark of the participant in mm, and records this for the value of pain severity. The severity of breast pain will be determined by the mean of breast pain scores (determined for all days and for days for which pain is greater than 0) at 4 weeks and 10 weeks of each treatment.
- Mean Days of Pain During the 10 Week Treatment Periods [ Time Frame: Approximately 12 weeks and at 24 weeks after randomization ]Participants will complete a breast pain diary indicating the sensation of pain on a daily basis. Mean number of days with pain during each 10 week treatment period will be calculated.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion criteria
- Noncyclic mastalgia or surgical scar-related pain occurring at least 2 days per week and for which the patient desires treatment
- Duration of pain > 2 months (noncyclic mastalgia) or > 4 months (surgical scar-related pain)
- Age > 18 years
- Satisfactory breast examination and directed ultrasound at site of pain (all ages) within 12 months
- Satisfactory mammogram (all women > 30 years of age) within 12 months
- Negative pregnancy test (all women who are premenopausal and have not had hysterectomy or tubal ligation)
Exclusion criteria
- Cyclic mastalgia (as defined above)
- Duration of pain > 2 months (noncyclic mastalgia) or > 4 months (surgical scar-related pain)
- Abnormal breast examination or imaging (abnormality at the site of pain or for which biopsy or surgical consultation is recommended)
- Known pregnancy, lactation, positive pregnancy test, or anticipated pregnancy within 6 months
- Asthma, that has been aggravated by oral nonsteroidal antiinflammatory agents
- Allergy, to diclofenac or any nonsteroidal antiinflammatory agents
- Rash or open lesions at the site on the breast where the topical agent would be applied
- Incomplete or abnormal healing (surgical scar-related pain)
- History of gastrointestinal ulceration, renal dysfunction (creatinine > 1.5), hepatic disease (known liver disease or aspartate aminotransferase (AST) twice normal levels), congestive heart failure and uncontrolled hypertension (blood pressure > 140/90)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00276419
United States, Minnesota | |
Mayo Clinic | |
Rochester, Minnesota, United States, 55905 |
Principal Investigator: | Robin L. Smith, M.D. | Mayo Clinic |
Responsible Party: | Robin L. Smith, MD; principal investigator, Division of General Internal Medicine, Mayo Clinic, Rochester Minnesota |
ClinicalTrials.gov Identifier: | NCT00276419 |
Other Study ID Numbers: |
92-05 |
First Posted: | January 13, 2006 Key Record Dates |
Results First Posted: | December 13, 2012 |
Last Update Posted: | December 20, 2012 |
Last Verified: | December 2012 |
Mastodynia Pain Neurologic Manifestations Diclofenac Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents |
Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |